Follicular lymphoma (FL) is a rare, slow-growing cancer that affects certain blood cells. People experiencing this form of non-Hodgkin lymphoma face multiple relapses over the course of their disease, which can run for years and sometimes decades. There is no cure. For a small number of patients, the disease progresses much faster, and they face five-year survival rates as low as 50 percent.
MI Philanthropy, in partnership with the Follicular Lymphoma Foundation (FLF), conducted an in-depth analysis of the FL landscape. This report identifies current and emerging therapeutic innovations in the FL field, and highlights efforts of the FLF to drive research into better treatments and find the fastest pathway to a cure. Importantly, this analysis demonstrates that although drug development for FL has been burgeoning in the past five years, there are key areas that should be addressed to accelerate the path to a cure.
Related Content
-
Prescription for Biomedical Innovation: Recommendations for the New Administration
FasterCures has long been at the forefront of shaping the national focus on biomedical innovation, with a singular goal of saving lives by accelerating scientific advances for all patients. FasterCures has been instrumental in advocating...Read Report -
World Leaders Heading to California for Milken Institute Global Conference: April 29-May 2
LOS ANGELES—More than 4,000 international leaders in business, government, science, philanthropy, academia, arts, and culture will meet in California for the 21 st Milken Institute Global Conference beginning April 29, 2018. Confirmed...Read Article -
Milken Institute Launches COVID-19 Vaccine and Treatment Tracker
Publicly available resource monitors the development of therapies to treat and prevent disease WASHINGTON, March 18, 2020 — The Milken Institute is launching a resource to help the public and policymakers track progress in the development...Read Article -
The White House Conference on Hunger, Nutrition, and Health
Investing in the intersection of food and healthcare is critical to achieving nutrition equity. Feeding Change submitted a letter informed by the Food Is Medicine Task Force that provides comments to inform the national strategy for the...Read LetterImageHolly Freishtat
Senior Director, Feeding Change, Milken Institute HealthHolly Freishtat is the senior director of Feeding Change at the Milken Institute. She is an experienced director, transformative leader, and strategist with a 20-year track record developing and implementing food system policies and programs. -
World Leaders to Descend on Singapore for the 10th Milken Institute Asia Summit, Celebrating a Decade of Progress, Action, and Impact
August 1, 2023 (SINGAPORE) - The annual Milken Institute Asia Summit, taking place from September 13 – 15, will convene regional and global leaders to discuss a wide range of issues and challenges shaping the Asia Pacific region including...Read ArticleImageYeen Chong
Associate Director, Milken Institute InternationalYeen Chee Chong is an associate director for Milken Institute International. Based in Singapore, he oversees and manages strategic communications with a wide range of global and regional media publications and partners. Chong works closely with colleagues in both Asia and the United States on planning and implementing global public relations and social media campaigns. -
Everything You Ever Wanted to Know About Royalties and Their Monetization But Were Afraid to Ask
Each Venture Philanthropy transaction involves numerous complicated issues: governance, intellectual property ownership and licensing, termination, indemnification, and publication, among others, but the issue that encompasses the most...Read Report -
Lessons of the Millennium Development Goals
Did the United Nations' ambitious Millennium Development Goals improve the health of people in emerging regions of the world? In this paper, a discussion of the precursors of higher living standards and better health, Milken Institute...Read Report -
Moonshots for Youth Mental Health and Well-Being: Exploration of Big Bets and Bold Goals
Good mental health is critical to overall health and well-being, but a cycle of almost endless stressors, stigma, and systemic barriers to accessing quality care have brought America’s collective mental health to a breaking point. In 2018...Read Report -
Type 1 Diabetes Autoantibody Screening Implementation Roadmap: 2022 REPORT UPDATE
In April 2021, the Milken Institute, with generous funding from the Leona M. and Harry B. Helmsley Charitable Trust, published a report focused on the implementation of type 1 diabetes (T1D) autoantibody screening in the general population...Read Report -
Guiding the Care Journey: Building Dementia Workforce and System Capacity through Care Navigation
This report covers the challenges that the US health-care system is facing as it prepares to meet the growing demand for care among individuals living with Alzheimer’s disease and related dementias (ADRD). It suggests that implementing care...Read Report11Mac McDermott and Diane Ty -
Patients Most In Need Face Obstacles to Participating in Life-Saving Clinical Trials According to a New Milken Institute Report
June 24, 2024 (Washington, DC)— Clinical trials can provide the possibility to obtain novel treatments for conditions and diseases that are not yet commercially available. Yet, these lifesaving treatments are often difficult or impossible...Read ArticleImagePaul Guequierre
Director, Strategic CommunicationsPaul Guequierre is the director of strategic communications. In this role, he works to increase the profile of Milken Institute in the media, raise the visibility of issues important to the organization and its stakeholders, and expand the Institute's digital presence. -
Optimizing the Food and Drug Administration’s Use of and Processes for Advisory Committees
The FasterCures team at the Milken Institute is honored to provide its response to the Request for Comments on Optimizing the Food and Drug Administration’s Use of and Processes for Advisory Committees; Public Meeting; Request for Comments...Read LetterImageEsther Krofah
Executive Vice President, Milken Institute HealthEsther Krofah is the executive vice president of Milken Institute Health, leading FasterCures, Public Health, the Future of Aging, and Feeding Change. She has extensive experience managing efforts to unite diverse stakeholders to solve critical issues and achieve shared goals that improve patients’ lives.